FDA approves sorafenib for thyroid carcinoma

By November 25, 2013 August 8th, 2017 2013 News Releases, News Releases, Thyroid Cancer

From the American Thyroid Association:
In collaboration with the Food and Drug Administration (FDA), and as a service to our members, ATA will provide updates on recent FDA approvals and other important FDA actions (e.g., updated safety information, new prescribing information) pertaining to therapies for cancer patients. Read More…